---
title: 'Clinical factors linked to the type of respiratory medication in COPD: results
  from the COSYCONET cohort'
date: '2023-11-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37936408/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231108170854&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Using data from a large, close to real-life observational
  cohort, we identified factors linked to the use of various types of respiratory
  COPD medication. Overall, use was consistent with GOLD recommendations. Beyond this,
  we identified other correlates of medication use that may help us to understand
  and improve therapy decisions in clinical ...'
disable_comments: true
---
CONCLUSION: Using data from a large, close to real-life observational cohort, we identified factors linked to the use of various types of respiratory COPD medication. Overall, use was consistent with GOLD recommendations. Beyond this, we identified other correlates of medication use that may help us to understand and improve therapy decisions in clinical ...